"High Content Analyse" -
Automatisierte Bildanalyse, Anwendung, Herausforderung und Innovation
Am 12.03.2015 in Darmstadt
08:00 |
09:00 |
Registration |
||
09:00 |
09:05 |
Begrüßung / Opening Remarks |
Dr. Anthony Zerlin, |
ELRIG.de e.V. |
09:05 |
09:40 |
Past, presence and future of High Content Screening. Big biology, big data and smart machines |
Dr. Urban Liebel
|
Acquifer GmbH, Karlsruhe |
09:40 |
09:50 |
Snapshot: Innovative Oberflächen für die Mikroskopie, das High Content Screening und die automatisierte Bildverarbeitung |
Dr. Rainer Heller |
Greiner Bio-One GmbH, |
09:50 |
10:00 |
Snapshot: Kinetics v Endpoint – Seeing through time brings new insights into chemotaxis and other label free assays |
Dr. Peter Djali |
Essen Bioscience, Welwyn Garden City, UK |
10:00 |
10:30 |
Light Sheet-based Fluorescence Microscopy (LSFM) provides new means for working with three-dimensional cell and tissue cultures |
Prof. Dr.
|
Institut für Zellbiologie und Neurowissenschaft, Uni Frankfurt am Main |
10:30 |
10:50 |
Kaffeepause / Coffee Break / Networking / Exhibition |
||
10:50 |
11:00 |
Snapshot: Disease modeling and phenotypic screening with human iPSC tissue cells: Combining human biology and HCI to re-invigorate drug discovery |
Dr. Sabine Lange |
Cellular Dynamics International., Inc. Madison, USA |
11:00 |
11:30 |
Chromobodies and the Fluorescent 2-Hybrid assay: real time visualization of proteins and protein-protein interactions for high content analysis |
Prof. Dr.
|
Universität Tübingen, Pharmazeutische Biotechnologie |
11:30 |
12:00 |
High Content Screening using iPS-derived neuronal progenitors to find compounds counteracting epigenetic gene silencing in Fragile X syndrome |
Dr.
|
Novartis Pharma AG, Basel
|
12:00 |
12:30 |
High content analysis for neuronal, synaptic and dendritic spine characterizations applied from target validation to drug screening |
Dr. Karsten Kottig |
Evotec AG, Hamburg |
12:30 |
14:00 |
Mittagspause / Lunch Break / Networking / Exhibition |
||
14:00 |
14:30 |
High-Content Screening (HCS) using two- and threedimensional cell culture systems for the discovery and validation of novel small molecule lead candidates |
Dr. Stefanie Bunse
|
Bayer Pharma AG , Berlin |
14:30 |
14:40 |
Are images your main concern? How to keep images at the center of your research |
Dr. André Stephan
|
Genedata, Basel |
14:40 |
15:00 |
Snapshot: Multiplexed high content hepatotoxicity assays using iPSC-derived hepatocytes |
Dr. Christian Holz |
Molecular Devices |
15:00 |
15:30 |
Use of High Content Imaging for preclinical safety assessment at Roche |
Dr. Stefan Kustermann
|
Hoffmann-La Roche AG, Basel
|
15:30 |
16:00 |
Multiplexed Screening - Developing novel image based cell assays for HCS platforms |
Dr. Philip Denner
|
Deutsches Zentrum für Neurodegenerative Erkrankungen, Bonn
|
16:00 |
16:15 |
Kaffeepause / Coffee Break / Networking / Exhibition |
||
16:15
|
16:45 |
How does modular software speed up development of High-Content-Analysis workflows |
Prof. Dr. Thomas Berlage
|
Fraunhofer-Institut für Angewandte Informationstechnik FIT, St. Augustin |
16:45 |
17:15 |
Open source tools for advanced HCS: CellProfiler and KNIME |
Dr. Marc Bickle
|
Max-Planck-Institut für |
17:15 |
17:30 |
Abschlussbemerkungen / Wrap Up |
Dr. Anthony Zerlin |
ELRIG.de e.V. |
Stand: 18.02.2015 Die angegebenen Zeiten können sich ein wenig verschieben / Times may change slightly